Atlas Trials

Perioperative Cancer Cell Dissemination and Systemic Immune Suppression in Resectable Ductal Pancreatic Adenocarcinoma

Clinical trial NCT00495924 · COMPLETED

Trial details

NCT number
NCT00495924
Sponsor
KU Leuven
Status
COMPLETED
Study type
OBSERVATIONAL
Pancreatic NeoplasmsAdenocarcinomaNeoplasm Circulating CellsTumor Markers, BiologicalMonitoring, Immunologic
Start date
2006-10-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.